(Q58449918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Comparing the cost of epilepsy across eight European countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

D C Heaney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S D Shorvon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

89-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

Cost of epilepsy in the United States: a model based on incidence and prognosis.

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Methodological issues in estimating the cost of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

The economics of parallel trade

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

International price comparisons for pharmaceuticals. Measurement and policy issues

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Ensuring Appropriate Care in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Uptake and costs of care for epilepsy: findings from a U.K. regional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

The concept of cost in the economic evaluation of health care. A theoretical inquiry.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Single European currency and Monetary Union. Macroeconomic implications for pharmaceutical spending

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Costing of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Cost of refractory epilepsy in adults in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Costs and cost-minimisation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Epidemiology of the epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

International comparison of drug consumption: impact of prices.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

The pros and cons of a single 'Euro-price' for drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900168-6

7 January 2021

10.1016/S0920-1211(00)00168-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164697%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference